Clinical trial
Analysis of Retinal Vessel Reaction and Monitoring of Circulation Parameters During Bevacizumab Therapy
NCT00740168 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Retinal Vessel Reaction and Monitoring of Circulation Parameters During Bevacizumab Therapy
- Lead sponsor
- Technische Universität Dresden
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- April 30, 2009
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer